NCT04430530
- Conditions
- CD19 Negative B-cell Malignancies
- Locations
-
- Shenzhen Geno-Immune Medical Institute Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying CD19 Negative B-cell Malignancies. Study availability and eligibility vary by location and protocol.
NCT04430530